The use of Pentostam liposomes in the chemotherapy of experimental leishmaniasis.
about
Visceral leishmaniasis in the BALB/c mouse: antimony tissue disposition and parasite suppression after the administration of free stibogluconateTherapy with sodium stibogluconate in stearylamine-bearing liposomes confers cure against SSG-resistant Leishmania donovani in BALB/c miceSimilarities of lipid metabolism in mammalian and protozoan cells: an evolutionary hypothesis for the prevalence of atheromaLiposome formulations with prolonged circulation time in blood and enhanced uptake by tumorsAntileishmanial activities of stearylamine-bearing liposomesIn vitro lysis of the bloodstream forms of Trypanosoma brucei gambiense by stearylamine-bearing liposomesAntileishmanial activity of liposome-encapsulated amphotericin B in hamsters and monkeysTreatment of experimental cutaneous leishmaniasis with liposome-intercalated amphotericin B.Hepatic uptake and degradation of unilamellar sphingomyelin/cholesterol liposomes: a kinetic study.Development of new derivatives of primaquine by association with lysosomotropic carriers.Antileishmanial drug targeting through glycosylated polymers specifically internalized by macrophage membrane lectins.Highly deformable and highly fluid vesicles as potential drug delivery systems: theoretical and practical considerations.Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs.Drug delivery strategies for therapy of visceral leishmaniasis.Nanoliposomal artemisinin for the treatment of murine visceral leishmaniasisNew delivery strategies for the old pentavalent antimonial drugs.Leishmaniasis. Currently recommended treatment.Drug resistance in leishmaniasis: current drug-delivery systems and future perspectives.Drug delivery systems. 1. site-specific drug delivery using liposomes as carriers.Association of water extract of green propolis and liposomal meglumine antimoniate in the treatment of experimental visceral leishmaniasis.Preparation and use of liposomes in the treatment of microbial infections.Targeting of liposomes to tumor cells in vivo.Combination therapy using sodium antimony gluconate in stearylamine-bearing liposomes against established and chronic Leishmania donovani infection in BALB/c Mice.The chemotherapy of protozoal infections: whither?Uptake and intracellular processing of targeted and nontargeted liposomes by rat Kupffer cells in vivo and in vitro.The six diseases of WHO. LeishmaniasisDevelopment of liposomes loaded with anti-leishmanial drugs for the treatment of cutaneous leishmaniasis.Mixed formulation of conventional and pegylated liposomes as a novel drug delivery strategy for improved treatment of visceral leishmaniasis.Targeting of mannosylated liposome incorporated benzyl derivative of Penicillium nigricans derived compound MT81 to reticuloendothelial systems for the treatment of visceral leishmaniasis.Accelerated Blood Clearance (ABC) Phenomenon Favors the Accumulation of Tartar Emetic in Pegylated Liposomes in BALB/c Mice Liver.The therapeutic effect of sodium stibogluconate in BALB/c mice infected with Leishmania donovani is organ-dependent.
P2860
Q28343232-D87E210D-BF77-4AA1-ACE4-08A5C89E3892Q28477398-124B8916-BDED-4D64-B3DF-A94274400B23Q28776654-D2BC4C6D-0516-4CAF-AAC7-A34131DFC318Q33649082-33572CCB-1BC8-47FC-BC56-485C58A333C7Q33979887-DF827CE0-5447-4362-8DFF-EDBCB734C7F8Q35311986-C7B93726-2E3A-4F75-8157-AB413E12CEAEQ35653579-404F1E46-B566-4641-B49D-851AB2BD5D6CQ35760259-F5FF7AA9-FA1D-4586-8853-B075A7158A5AQ36397370-47A61A82-79B8-455E-9EE6-CAB8C421EC1DQ36675517-69611EAC-B206-4242-BD7B-8298807F4CF5Q36757841-012872A8-7321-4ECE-9705-4A2AEE9B920AQ37125441-3106B88A-6E42-4490-BF4B-2ACB646DCF57Q37589185-EAA8993A-A079-4586-9B56-61177F3F29C5Q37702257-6133F8C3-6E22-4DA6-8266-297A60AE3C1AQ37722715-7554A8BA-2BE7-43F1-BC02-4C2AC07B10B3Q37804399-18D4B2E9-77B8-47F9-A603-BAAB94CC80C6Q37883941-7281E71F-00E3-4068-8832-BFDA976B41A6Q38154347-BB402512-E988-4167-A308-1F6CEE1F2FFDQ38689437-DE55B370-54D7-4042-B224-06BF315B01ACQ39051630-CDAD37BC-ADFB-4E5A-A959-461D2BAA5C0CQ39654122-8A4712E8-89CD-44C8-A1E0-92AC11A64E7EQ39696588-156316D4-E653-45F3-98DF-76A98365012AQ39955167-512052F8-5CEC-4BB1-8F93-8BC5746647C1Q40125390-F86E7F1D-410E-4ED6-AC9D-FFB2F9908767Q41918026-27D2EF19-485C-4749-8522-3438A0014E1EQ42357040-55343A0F-F2EE-4056-BE68-FF95D72DC76AQ44058897-1403BC35-6937-4F8C-B7EE-CF0B280D3A5FQ45763061-CB6868B7-DF53-4A50-98EF-8D190DC1A25CQ46731824-FAFDA207-C741-4C39-9974-101398C8BF0AQ52624382-0760DAC1-2BC2-4DB2-BCE9-8FB0CE0AAB67Q54384876-5DFAA50A-29F4-44B5-B46C-265E8E7874BB
P2860
The use of Pentostam liposomes in the chemotherapy of experimental leishmaniasis.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
1977年论文
@zh
1977年论文
@zh-cn
name
The use of Pentostam liposomes in the chemotherapy of experimental leishmaniasis.
@en
type
label
The use of Pentostam liposomes in the chemotherapy of experimental leishmaniasis.
@en
prefLabel
The use of Pentostam liposomes in the chemotherapy of experimental leishmaniasis.
@en
P2093
P2860
P1476
The use of Pentostam liposomes in the chemotherapy of experimental leishmaniasis.
@en
P2093
P2860
P304
P356
10.1016/0035-9203(77)90155-9
P577
1977-01-01T00:00:00Z